Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Kabraji received his medical degree from Oxford University Medical School, Oxford, UK, in 2009. He completed his residency in Internal Medicine at the Massachusetts General Hospital in Boston, MA in 2013. Dr Kabraji completed his medical oncology fellowship in the Dana-Farber/Partners Cancer Care Hematology/Oncology Program in June 2017, where he was a post-doctoral fellow in the laboratory of Dr. Sridhar Ramaswamy at Massachusetts General Hospital Cancer Center. Dr. Kabraji now serves as a medical oncologist in the Susan F. Smith Center for Women’s Cancers in the Breast Oncology Program, an associate physician in the Oncology Division of Brigham and Women’s Hospital, and an Instructor in Medicine at Harvard Medical School. As a physician-scientist, Dr. Kabraji is active in laboratory investigation and translational research focusing on understanding non-genetic mechanisms of drug resistance in localized and metastatic breast cancer.
Dana-Farber Cancer Institute450 BrooklineBoston, MA 02215Get Directions
Dana-Farber Cancer Institute - Chestnut Hill300 Boylston StreetNewton, MA 02459Get Directions